Brought to you by 
OccuLogix completes IPO
15 Dec 2004
Executive Summary
OccuLogix Inc. (blood filtration system to treat age-related macular degeneration, AMD) netted $62.5mm in its initial public offering of 5.6mm shares at $12. Selling shareholders placed 2.8mm other shares.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
OccuLogix completes IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice